Trials / Completed
CompletedNCT01382901
Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)
A Phase 2a Study Evaluating the Efficacy and Safety of a Novel Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- American Regent, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to evaluate the safety of 2 dosage regimens of Intravenous (IV) iron Ferric Carboxymaltose (FCM) in comparison to placebo in patients with Restless Legs Syndrome (RLS)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ferric Carboxymaltose (FCM) | |
| DRUG | Placebo |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2007-07-01
- Completion
- 2007-07-01
- First posted
- 2011-06-27
- Last updated
- 2018-02-20
- Results posted
- 2011-06-27
Source: ClinicalTrials.gov record NCT01382901. Inclusion in this directory is not an endorsement.